Your browser doesn't support javascript.
loading
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation.
Hatterer, Eric; Barba, Leticia; Noraz, Nelly; Daubeuf, Bruno; Aubry-Lachainaye, Jean-Pierre; von der Weid, Benoit; Richard, Françoise; Kosco-Vilbois, Marie; Ferlin, Walter; Shang, Limin; Buatois, Vanessa.
Afiliação
  • Hatterer E; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Barba L; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Noraz N; b INSERM U1217, Institut NeuroMyoGène, Lyon , University Claude Bernard Lyon 1 , Lyon , France.
  • Daubeuf B; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Aubry-Lachainaye JP; c Flow cytometry core facility , Faculty of Medicine , Geneva , Switzerland.
  • von der Weid B; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Richard F; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Kosco-Vilbois M; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Ferlin W; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Shang L; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
  • Buatois V; a Exploratory Sciences , NovImmune SA , Plan les Ouates , Switzerland.
MAbs ; 11(2): 322-334, 2019.
Article em En | MEDLINE | ID: mdl-30569825
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Anticorpos Biespecíficos / Antígenos CD19 / Antígeno CD47 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Anticorpos Biespecíficos / Antígenos CD19 / Antígeno CD47 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article